Antipyrine clearance and metabolite formation in primary biliary cirrhosis

Digestive Diseases and Sciences

Volumn 46, Issue 2, 2001, Pages 352-359

  Jorquera, F ^a,b,c   Almar, M ^a,b,c   Linares, A ^a,b,c   Olcoz J L ^a,b,c   Rodrigo, L ^a,b,c   Gonzalez Gallego J ^a,b,c  

^a Leon Hospital   (Spain)

^b UNIVERSITY OF LEÓN   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Antipyrine; Metabolites; Primary biliary cirrhosis

Indexed keywords

4 HYDROXYPHENAZONE; BILIRUBIN; DRUG METABOLITE; HYDROXYMETHYLANTIPYRINE; NORPHENAZONE; PHENAZONE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DRUG CLEARANCE; DRUG HALF LIFE; DRUG SALIVA LEVEL; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER FAILURE; LIVER FUNCTION TEST; LIVER METABOLISM; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; ANTIPYRINE; BILIRUBIN; BIOPSY; CASE-CONTROL STUDIES; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; LOGISTIC MODELS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SALIVA; SEVERITY OF ILLNESS INDEX;

EID: 0035088518     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005661117739     Document Type: Article

References (32)

1. Primary biliary cirrhosis
2. New concepts in biliary cirrhosis
3. Accuracy of staging in primary biliary cirrhosis
4. Primary biliary cirrhosis
5. Serum bilirubin: A prognostic factor in primary biliary cirrhosis
6. Prognosis in primary biliary cirrhosis: Model for decision making
7. Antipyrine as a model drug to study hepatic drug-metabolizing capacity
8. Quantifying hepatic function in the presence of liver disease with phenazone (antipyrine) and its metabolites
9. Serial antipyrine clearance studies detect altered metabolic function during spontaneous and interferon-induced changes in chronic hepatitis B disease activity
10. Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis
11. Correlation between microsomal enzyme activity and antipyrine elimination in alcoholic and nonalcoholic with various liver diseases
12. Pharmacokinetics of midazolam following intravenous and oral administration in patients with chronic liver disease and in healthy subjects
13. Antipyrine clearance in chronic and neoplastic liver diseases: A study of 518 patients
14. Antipyrine clearance and metabolite excretion in patients with chronic hepatitis C
15. Fibrotic process and drug metabolism in alcoholic liver disease
16. Antipyrine metabolism during chemotherapy with 5-fluoracil plus folinic acid in patients with liver metastases from primary colorrectal cancer
17. Disposition of antipyrine in paiients with extensive metastatic liver disease
18. Antipyrine clearance and response to interferon treatment in patients with chronic active hepatitis C
19. Clinical significance of serum bilirubin levels under ursodeoxycholate acid therapy in patients with primary biliary cirrhosis
20. Antipyrine kinetics in patients with primary biliary cirrhosis
21. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
22. Assay of antipyrine and its metabolites in plasma, saliva and urine by high-performance liquid chromatography and some preliminary results in man
23. Improved high-performance liquid chromatographic assay of antipyrine, hydroxymethylantipyrine, 4-hydroxyantipyrine and norantipyrine in urine
24. Accuracy and clinical utility of simplified tests of antipyrine metabolism
25. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial
26. Serial quantitative liver function tests in patients with primary biliary cirrhosis
27. Clearance of antipyrine: Dependence on quantitative liver function
28. Antipyrine elimination in patients with alcoholic and non-alcoholic cirrhosis
29. Identification of the human hepatic cytochrome P450 involved in the in vitro oxidation of antipyrine
30. Antipyrine as a probe for human oxidative metabolism: Identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation
31. Age and cytochrome P450-linked drug metabolism in humans: An analysis of 226 subjects with equal histopathological conditions
32. The effect of age and sex on metabolism and urinary excretion of antipyrine